Characterization of the A2B Adenosine Receptor from Mouse, Rabbit, and Dog
Authors:
- John A. AuchampachJAJohn A. Auchampach
- Laura M. KrecklerLKLaura M. Kreckler
- Tina C. WanTWTina C. Wan
- Jason E. MaasJMJason E. Maas
- Dharini van der HoevenDHDharini van der Hoeven
- Elizabeth GizewskiEGElizabeth Gizewski
- Jayashree NarayananJNJayashree Narayanan
- Garren E. MaasGMGarren E. Maas
- 1 April 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 329 (1) , 2-13
Abstract
We have cloned and pharmacologically characterized the A2B adenosine receptor (AR) from the dog, rabbit, and mouse. The full coding regions of the dog and mouse A2BAR were obtained by reverse transcriptase-polymerase chain reaction, and the rabbit A2BAR cDNA was obtained by screening a rabbit brain cDNA library. It is noteworthy that an additional clone was isolated by library screening that was identical in sequence to the full-length rabbit A2BAR, with the exception of a 27-base pair deletion in the region encoding amino acids 103 to 111 (A2BAR103-111). This 9 amino acid deletion is located in the second intracellular loop at the only known splice junction of the A2BAR and seems to result from the use of an additional 5′ donor site found in the rabbit and dog but not in the human, rat, or mouse sequences. [3H]3-Isobutyl-8-pyrrolidinoxanthine and 8-[4-[((4-cyano-[2,6-3H]-phenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)xanthine ([3H]MRS 1754) bound with high affinity to membranes prepared from human embryonic kidney (HEK) 293 cells expressing mouse, rabbit, and dog A2BARs. Competition binding studies performed with a panel of agonist (adenosine and 2-amino-3,5-dicyano-4-phenylpyridine analogs) and antagonist ligands identified similar potency orders for the A2BAR orthologs, although most xanthine antagonists displayed lower binding affinity for the dog A2BAR compared with A2BARs from rabbit and mouse. No specific binding could be detected with membranes prepared from HEK 293 cells expressing the rabbit A2BAR103-111 variant. Furthermore, the variant failed to stimulate adenylyl cyclase or calcium mobilization. We conclude that significant differences in antagonist pharmacology of the A2BAR exist between species and that some species express nonfunctional variants of the A2BAR due to “leaky” splicing.Keywords
This publication has 41 references indexed in Scilit:
- The 2.6 Angstrom Crystal Structure of a Human A2AAdenosine Receptor Bound to an AntagonistScience, 2008
- Design of (N)-methanocarba adenosine 5′-uronamides as species-independent A3 receptor-selective agonistsBioorganic & Medicinal Chemistry Letters, 2008
- Recent improvements in the development of A2B adenosine receptor agonistsPurinergic Signalling, 2008
- High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled ReceptorScience, 2007
- The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground StateMolecular Pharmacology, 2007
- Cardioprotection by Ecto-5′-Nucleotidase (CD73) and A 2B Adenosine ReceptorsCirculation, 2007
- A2BReceptors Mediate Antimitogenesis in Vascular Smooth Muscle CellsHypertension, 2000
- cDNA cloning and characterization of A3i, an alternatively spliced rat A3 adenosine receptor variantFEBS Letters, 1996
- Cloned adenosine A3 receptors: Pharmacological properties, species differences and receptor functionsTrends in Pharmacological Sciences, 1994
- Molecular cloning of a novel putative G‐protein coupled receptor expressed during rat spermiogenesisFEBS Letters, 1991